Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).
<h4>Background</h4>The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of pravastatin, demonstrated a 19% reduction in coronary outcomes (p=0.006) after a mean of 3.2 years, with no impact on stroke outcomes or all-cause mortality. However, t...
Saved in:
| Main Authors: | Suzanne M Lloyd, David J Stott, Anton J M de Craen, Patricia M Kearney, Naveed Sattar, Ivan Perry, Christopher J Packard, Andrew Briggs, Laura Marchbank, Harry Comber, J Wouter Jukema, Rudi G J Westendorp, Stella Trompet, Brendan M Buckley, Ian Ford |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2013-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0072642 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER).
by: Rosalinde K E Poortvliet, et al.
Published: (2012-01-01) -
Factor VII Activating Protease Polymorphism (G534E) Is Associated with Increased Risk for Stroke and Mortality
by: Stella Trompet, et al.
Published: (2011-01-01) -
Pharmacotherapy with statins in highand very high-risk elderly patients
by: V. V. Simerzin, et al.
Published: (2020-11-01) -
How to prosper during the coming bad years /
by: Ruff, Howard J.
Published: (1979) -
Effect of Pravastatin as an Adjunctive Therapeutic for Mitral Insufficiency with Hyperlipidemia in a Dog
by: Yu Sahashi, et al.
Published: (2021-01-01)